MRI-guided focused ultrasound (MRgFUS) is an incisionless surgery that uses converging sound waves to treat tremor and other movement symptoms, with no cuts, no implants, and real-time feedback while you are awake. Explore how it works, whether you may be a candidate, and how it compares to other options.
MRI-guided focused ultrasound (MRgFUS, or just FUS) focuses hundreds of ultrasound beams through the intact skull to a precise target deep in the brain to create a small, controlled lesion (disconnection) that interrupts the abnormal circuit driving your symptoms. There is no incision and no implanted device.
Real-time MRI thermometry measures the temperature at the exact focus point, allowing the care team to confirm accuracy before the definitive treatment is delivered.
The ultrasound beams pass through the skull without cutting. There is no opening in the scalp or skull, no implanted hardware, and no general anesthesia.
You remain awake throughout so your care team can test symptom improvement in real time. Low-energy test pulses are given first so you can provide feedback before the permanent lesion is made.
Most patients are discharged the same day. Surgical recovery is typically quick and no follow-up for device programming (as for DBS) is needed.
MRgFUS is surgery because it achieves its effect by creating a permanent, targeted change in brain tissue. DBS, on the other hand, requires the surgical implantation of a device to deliver reversible, adjustable stimulation. Both are effective options; they work differently and suit different patients.
Ultrasound energy is delivered by individual "transducer" elements. Each transducer element on its own would spread energy across a wide volume of tissue. The waves of energy from each transducer will add or cancel, depending on their relative phases (where the peaks and troughs of the wave line up). The key is timing: when every element is delayed by exactly the right amount, all waves converge at the target simultaneously, arriving "in phase" and summing to produce an intensity far beyond what any single element could achieve.
Drag the target to steer the focus and watch each element's phase (shown by ring color) update in real time. Adjust the sliders to explore how the number of elements and phase accuracy (affected by skull density) shape the focal spot. Note that higher element counts are especially useful to correct for phase error, such as skull distortion.
Select your diagnosis, then click any symptom to see how FUS typically addresses it.
Select a symptom to see how FUS typically affects it.
MRgFUS is FDA-approved for three brain targets, each addressing different symptoms. Select a target below to learn more.
Axial slice · Targets shown bilaterally
FUS creates a lesion on one side of the brain at a time. Because both sides of the brain can be affected by movement disorders, the question of whether to treat one side or both is an important part of your evaluation.
A single FUS procedure treats one hemisphere of the brain and affects movement on the opposite side of the body. For most patients, the dominant hand (and thus the non-dominant hemisphere) is treated first, as this typically provides the greatest functional benefit.
Unilateral treatment is the standard first procedure. If the non-treated side causes significant disability after the first procedure, a second procedure may be considered after the required interval.
Bilateral FUS is FDA-approved and is performed as two staged procedures — one per side — with a mandatory minimum interval of 9 months between treatments. This interval allows for safety assessment and full recovery of the first side.
Treating both hemispheres increases the risk of dysarthria (slurred speech), dysphagia (swallowing difficulty), and subtle changes in cognition or balance. These risks are carefully weighed against the expected benefit, particularly for axial symptoms like voice tremor that require bilateral treatment to improve.
Not everyone with a movement disorder is an ideal candidate for FUS. Several factors — including diagnosis, skull anatomy, and overall health — determine whether FUS is appropriate for you.
Select a category above, then tap any factor to read more.
The SDR is a CT-derived measure of how porous your skull bone is. The skull contains an inner cancellous (spongy) bone layer that absorbs and scatters ultrasound — the more porous this layer, the lower the SDR. A higher SDR indicates denser, more solid bone that transmits energy more efficiently. Drag the slider below to see how skull density appears on CT.
From your first consultation through the day of treatment and beyond — here is what the FUS process looks like at each stage.
The data below reflect published outcomes from pivotal clinical trials and real-world studies. Individual results vary; your specific outcome will depend on your diagnosis, target, and skull characteristics.
Temporary side effects during or immediately after FUS are common and typically resolve within days to weeks. These include: mild imbalance or unsteadiness (most common), tingling or numbness in the hand or face, fatigue, and headache. Serious complications are uncommon but include significant dysarthria (slurred speech), particularly with bilateral treatment.
Both FUS and DBS are effective surgical treatments for movement disorders. The right choice depends on your diagnosis, symptoms, anatomy, and personal priorities. Toggle below to compare.
| Feature | FUS (MRgFUS) | Deep Brain Stimulation |
|---|---|---|
| Mechanism | Thermal ablation — permanent lesion in brain tissue | Chronic electrical stimulation via implanted electrodes |
| Incision | None — no skin cuts | Small burr holes in skull + incision for pulse generator (chest) |
| Reversibility | Permanent — lesion cannot be undone | Reversible — device can be turned off or removed |
| Adjustability | None — effect is fixed at time of treatment | Fully adjustable — stimulation parameters tuned over time |
| Anesthesia | Awake (local); mild sedation available | Varies: awake, or asleep with robotic / MRI guidance |
| Hospital Stay | Same-day discharge (typical) | 2 or 3 stages, one of which requires a 1-night stay |
| Bilateral Treatment | Staged: two separate procedures, ≥ 9 months apart | Both sides can be treated in a single procedure |
| Effect Onset | Immediate (often felt during procedure) | After device activation and programming (weeks to months) |
| Long-term Maintenance | None — no hardware to manage | Battery replacement every ~3–5 years; programming visits |
| MRI After Procedure | Unrestricted | Conditional — head/body MRI under specific conditions |
Neither FUS nor DBS is universally "better" — they are complementary tools suited to different patients and priorities. Your neurosurgeon and movement disorders neurologist will help you weigh these options based on your specific situation.
This educational resource was developed by the Division of Functional and Epilepsy Neurosurgery at Brown University Health to help patients and families understand focused ultrasound treatment for movement disorders. Our surgeons specialize in the full range of functional neurosurgical options — including FUS, DBS, and ablative procedures — and work closely with the movement disorders neurology team to ensure each patient receives the most appropriate, individualized care.


